Celiac Disease in ChildrenCeliac DiseasePatient-reported Outcome Measures
Investigational drug(s) / intervention(s)
Interview and scale development
Interview and scale development: Interview and scale development
Study summary
A multicentre, prospective observational study to develop the CELIAC-Q KIDS patient reported outcome measure for children and adolescents with celiac disease. The CELIAC- Q KIDS will contain a comprehensive set of independently functioning scales designed to measure outcomes that matter to children with celiac disease, as well as scales to measure patients experience with the gluten-free diet.
Eligibility
Sex
ALL
Min age
4 Years
Max age
17 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Patients diagnosed with celiac disease.
* Pediatric patients (18 years and younger).
* Ability to understand and communicate in the English language
Exclusion Criteria:
* Patients who do not have celiac disease.
* Non-pediatric patients (over 18).
* Unable to understand and communicate in the English language
Primary outcome measure(s)
Development of the patient-reported outcome measure: Consensus on items that will comprise the newly developed disease-specific patient-reported outcome measure for pediatric celiac disease — 48 Months Development of the CELIAC-Q KIDS scales: qualitative interview and survey-based data will be analyzed qualitatively to develop and refine the items that comprise the scales
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
